Stockscreener 앱 받기
2.62
2.96%
-0.08
전일 마감가:
$2.70
열려 있는:
$2.6
하루 거래량:
41,405
Relative Volume:
0.30
시가총액:
$96.31M
수익:
-
순이익/손실:
$-13.27M
주가수익비율:
-15.98
EPS:
-0.164
순현금흐름:
$-7.70M
1주 성능:
+2.75%
1개월 성능:
+27.80%
6개월 성능:
+92.29%
1년 성능:
+125.86%
1일 변동 폭
$2.5605
$2.6876
1주일 범위
$2.56
$2.83
52주 변동 폭
$0.9016
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
OKYO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.5608 | 101.55M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.69 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.03 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.96 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.90 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.67 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Okyo Pharma Limited 주식(OKYO)의 최신 뉴스
How OKYO Pharma Limited (OK11) stock reacts to fiscal policiesDividend Hike & Low Drawdown Trading Strategies - newser.com
Has OKYO Pharma Limited found a price floorFed Meeting & Weekly Momentum Picks - newser.com
How OKYO Pharma Limited stock valuations compare to rivalsJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - newser.com
Long term hold vs stop loss in OKYO Pharma LimitedWeekly Trade Analysis & Verified Swing Trading Watchlists - newser.com
Will OKYO Pharma Limited stock benefit from commodity pricesMarket Movers & Weekly Consistent Profit Watchlists - newser.com
Is OKYO Pharma Limited (OK11) stock a top pick for value investorsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
OKYO Pharma Limited stock chart pattern explainedJuly 2025 Fed Impact & Stepwise Trade Signal Guides - newser.com
Will OKYO Pharma Limited (OK11) stock enhance shareholder valueEarnings Recap Summary & Daily Stock Momentum Reports - newser.com
Will OKYO Pharma Limited (OK11) stock profit from automation waveLayoff News & Smart Swing Trading Techniques - newser.com
What sentiment indicators say about OKYO Pharma Limited stock2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
Will OKYO Pharma Limited stock deliver better than expected guidanceJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Is OKYO Pharma Limited stock safe for conservative investorsJuly 2025 Action & Fast Exit and Entry Strategy Plans - newser.com
What technical signals suggest for OKYO Pharma Limited stockJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com
Individual investors invested in OKYO Pharma Limited (NASDAQ:OKYO) up 16% last week, insiders too were rewarded - simplywall.st
Key metrics from OKYO Pharma Limited’s quarterly dataQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Is OKYO Pharma Limited a candidate for recovery playWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Will OKYO Pharma Limited (OK11) stock announce a stock split2025 Volatility Report & Technical Entry and Exit Tips - newser.com
Will OKYO Pharma Limited stock outperform Nasdaq index2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Market reaction to OKYO Pharma Limited’s recent news2025 Trading Recap & High Accuracy Trade Signal Alerts - newser.com
Strategies to average down on OKYO Pharma Limited2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Is OKYO Pharma Limited building a consolidation baseJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
OKYO Pharma CEO to present at BIO-Europe conference in Vienna By Investing.com - Investing.com South Africa
OKYO Pharma CEO to present at BIO-Europe conference in Vienna - Investing.com UK
OKYO Pharma to present positive Phase 2 Data for urcosimod at BIO-Europe 2025 - Proactive financial news
OKYO Pharma to Present at BIO-Europe 2025 Highlighting Urcosimod Progress - TipRanks
OKYO Pharma to Present at BIO-Europe 2025 in Vienna - The Manila Times
Okyo Pharma Limited (OKYO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):